Emily, most people with concerns about the Covid-19 vaccine are legitimately focused on the immediate risks, i.e. pain, swelling, thrombocytopenia, cardiac arrest, anaphylaxis and Bell’s palsy. Given the large number of vaccine shots administered, most feel the risk of the vaccine is worth the reward.
But there are two 800 lb elephants in the room, that very few people are addressing, which are
1. Other allergic responses to autoimmunity, sepsis and organ failure (immune escape), and
2. The use of tumorigenic and tumor-derived cell lines in the creation of the vaccine.
As to #1 above, here are some of the "issues" that would concern me:
“In light of the information discussed above about the cross-reactivity of the SARS-CoV-2 proteins with human tissues and the possibility of either inducing autoimmunity, exacerbating already unhealthy conditions, or otherwise resulting in unforeseen consequences, it would only be prudent to do more extensive research regarding the autoimmune-inducing capacity of the SARS-CoV-2 antigens.”
“Our present study used human monoclonal antibodies against SARS-CoV-2 proteins, and we found reactivity with 28 out of 55 tested human antigens.”
“The third important question to consider is whether cross-reactivity between COVID-19 and human tissue can lead to autoimmune disease development either from the infection or directly from vaccination. Determining this can be an enormous task because the development of most autoimmune diseases may take 3 to 18 years (7). Segal and Shoenfeld have raised concerns for vaccine-induced autoimmunity by citing examples of how previous vaccinations have induced cross-reactive autoimmunity in susceptible subgroups.
They cite specific examples of how vaccine-induced cross-reactivity has led to the onset of systemic lupus erythematous, demyelinating autoimmune diseases, narcolepsy, and postural orthostatic tachycardia syndrome.”Tissues Affected
The reasoning is that immune response against the viral antigens following infection or vaccination can cross-react with human tissue antigens that share sequence homology with the virus, resulting in autoimmune reactivity, possibly followed by outright autoimmune disease (5, 10, 19, 24, 25). Some support for this proposed mechanism for the induction of autoimmunity was presented by Lyons-Weiler (5) when he compared immunogenic epitopes of SARS-CoV-2 to human proteins and found a high degree of homology with various tissues. These included heart muscle, skeletal muscle, thyroid gland, kidney, brain, pituitary gland, testes, lung, blood, gastrointestinal tract, eye, liver, bone marrow, adipose tissue, skin, and many ubiquitous proteins.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246018/https://www.frontiersin.org/articles/10.3389/fimmu.2020.617089/full As to #2 above:
"Immortalized Cell line - The cell line in which Janssen grows its adenovirus vector is a human embryonic cell line called PER.C6. The retinal tissue that launched the cell line was obtained following the elective abortion of a healthy, 18-week-old fetus. The AstraZeneca-Oxford COVID vaccine uses a different human embryonic cell line called HEK293T to propagate its adenovirus."
To produce a continuous cell line of this type — what is called an “immortalized” cell line — scientists must artificially manipulate the original cells, which otherwise would have finite lifespans. This is accomplished by introducing chemical exposures or rendering them cancerous. Because this manipulation introduces genetic changes into the cells, “cell populations and cellular mechanisms are altered.”
A senior FDA official warned over two decades ago about the inherent risks of using continuous cell lines for vaccine development, noting that such cell lines, “by definition” have abnormalities, and worriedly acknowledging their “potential for growing tumors in laboratory animals.”An FDA document published in late 2020 shows that these issues are far from resolved; explicitly referring to cell lines such as PER.C6 and HEK293T, the FDA author states:
“The use of tumorigenic and tumor-derived cells is a major safety concern” and observes that the cell lines contain “latent” or “quiet” threats that “might become active under vaccine manufacturing conditions.”The fact sheet for healthcare providers administering the J&J COVID vaccine specifies that each dose of vaccine “may … contain residual amounts of host cell proteins … and/or host cell DNA,” but the simplified fact sheet intended for vaccine recipients and their caregivers does not.
That means that unless vaccine recipients seek out the healthcare provider fact sheet, they’ll be unaware of this potentially crucial piece of information.
"The Italian vaccine research and advocacy organization, Corvelva, which has conducted detailed studies of DNA from aborted fetal cell lines in vaccines, warns that such DNA is abnormal and potentially tumor-causing. Corvelva concludes that vaccines of this type “should be considered defective and potentially dangerous to human health.”
"Along with a variety of other inactive ingredients, the J&J COVID vaccine also includes polysorbate-80, a stabilizer that studies have shown capable of transporting other substances across the blood-brain barrier."
The lack of long term safety trials should put both of these issues in the forefront of this discussion. This will turn out to be the largest vaccine human trial ever.
Emily, most people with concerns about the Covid-1... (